Translucent(US)
United States
- New York, New York
- 12/08/2025
- Seed
- $7,000,000
We’re tackling one of healthcare providers’ biggest hidden problems - FP&A work.
The business of healthcare is extremely complex - shifting regulation, multiple payment models, 100+ specialties, complex supply chains, complex operations, the list goes on.
This complexity requires CFOs to employ highly-skilled FP&A teams steeped in healthcare knowledge in order to understand business performance, identify revenue and cost improvement opportunities, and implement changes.
But here’s the problem - FP&A teams are bogged down by a never-ending queue of ad-hoc requests and weekly analyses that require hours, days, weeks to address:
- Data pulls and transformation across disparate sources
- Data analysis and manipulation in spreadsheets
- Deriving the ‘so-what from spreadsheets, contracts, etc.
- Taking action on key insights (human interaction or systems interactions)
This is manual and complex workflow is creating a no-win scenario for provider organizations
- FP&A teams feel like they can’t keep up with supporting the business and spend 90% of their time on ad-hoc requests and weekly analysis vs. strategic work
- The CFO and operating leaders feel like they are ‘flying blind’ and missing opportunities to improve P&L performance
- Industry Hospital & Health Care
- Website https://www.translucent.co/
- LinkedIn https://www.linkedin.com/company/translucentai/
Vesence | $9,000,000 | (Oct 30, 2025)
Sparrow BioAcoustics | $10,000,000 | (Oct 30, 2025)
Reflectiz | $22,000,000 | (Oct 30, 2025)
Mem0 | $24,000,000 | (Oct 30, 2025)
Valthos | $30,000,000 | (Oct 30, 2025)
Mondra | $13,206,500 | (Oct 30, 2025)
hoop.dev | Undisclosed Amount | (Oct 30, 2025)
IORGANBIO | $2,000,000 | (Oct 30, 2025)
FrontlineIQ | $3,300,000 | (Oct 30, 2025)
Homecourt | $8,000,000 | (Oct 30, 2025)
VentureMed Inc. | $28,000,000 | (Oct 30, 2025)
Recess | $30,000,000 | (Oct 30, 2025)